| 描述 | 锌指蛋白2 |
|---|
| 基因ID | 153527 |
|---|---|
| Uniprot Accession IDs | Q96NC0 |
| Ensembl ID | ENSG00000146007 |
| 原子符号 | Snu23 Ptg-12 |
| Chromosome | 5 |
| 序列 |
MASGSGTKNLDFRRKWDKDEYEKLAEKRLTEEREKKDGKPVQPVKRELLRHRDYKVDLESKLGKTIVITKTTPQSEMGGYYCNVCDCVVKDSINFLDHINGKKHQRNLGMSMRVERSTLDQVKKRFEVNKKKMEEKQKDYDFEERMKELREEEEKAKAYKKEKQKEKKRRAEEDLTFEEDDEMAAVMGFSGFGSTKKSY
|
| 同源种属 | 基因编号(Gene ID) | 基因名称(Gene Symbol) | 蛋白名称 | 种属编号(Tax ID) | 其它基因编号(Gene ID) | 来源 |
|---|---|---|---|---|---|---|
| Chimp | 736814 | ZMAT2 | zinc finger matrin-type 2 | 9598 | VGNC:4230 | OMA, EggNOG |
| Macaque | 697247 | ZMAT2 | zinc finger matrin-type 2 | 9544 | Inparanoid, OMA, EggNOG | |
| Mouse | 66492 | Zmat2 | zinc finger, matrin type 2 | 10090 | MGI:1913742 | Inparanoid, OMA, EggNOG |
| Rat | 679898 | Zmat2 | zinc finger, matrin type 2 | 10116 | RGD:1583592 | Inparanoid, OMA |
| Dog | 607047 | ZMAT2 | zinc finger matrin-type 2 | 9615 | VGNC:48639 | Inparanoid, OMA, EggNOG |
| Horse | ZMAT2 | zinc finger matrin-type 2 [Source:HGNC Symbol;Acc:HGNC:26433] | 9796 | OMA, EggNOG | ||
| Cow | 782132 | ZMAT2 | zinc finger matrin-type 2 | 9913 | VGNC:37191 | Inparanoid, OMA, EggNOG |
| Pig | 100621095 | ZMAT2 | zinc finger matrin-type 2 | 9823 | OMA, EggNOG | |
| Platypus | ZMAT2 | zinc finger matrin-type 2 [Source:HGNC Symbol;Acc:HGNC:26433] | 9258 | OMA, EggNOG | ||
| Anole lizard | 100557888 | zmat2 | zinc finger matrin-type 2 | 28377 | Inparanoid, OMA, EggNOG | |
| Xenopus | 448699 | zmat2 | zinc finger matrin-type 2 | 8364 | XB-GENE-1217476 | Inparanoid, OMA, EggNOG |
| Zebrafish | 324476 | zmat2 | zinc finger, matrin-type 2 | 7955 | ZDB-GENE-030131-3197 | Inparanoid, OMA, EggNOG |
| C. elegans | 176090 | snu-23 | Putative zinc finger matrin-type protein snu-23 | 6239 | Inparanoid, OMA, EggNOG | |
| S.cerevisiae | 851460 | SNU23 | U4/U6-U5 snRNP complex subunit SNU23 | 4932 | S000002256 | Inparanoid, EggNOG |
| 蛋白名称 | 规格与纯度 | 表达系统 | 蛋白标签 | 是否现货 | 查看详情 |
|---|
| 名称 | 规格与纯度 | 种属反应性 | 应用 | 是否现货 | 查看详情 |
|---|
| 疾病英文名称 | 疾病中文名称 | 疾病类型 | Mondoid | Direct Associated Targets |
|---|